|
Market Closed -
NYSE
00:00:00 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.530 USD | +2.02% |
|
-1.17% | +40.56% |
| Market Cap | 200M 179M 166M 150M 281M 18.98B 284M 1.99B 788M 9.95B 750M 734M 31.55B | P/E 2026 * |
10.3x | P/E 2027 * | 49.6x |
|---|---|---|---|---|---|
| Enterprise Value | 200M 179M 166M 150M 281M 18.98B 284M 1.99B 788M 9.95B 750M 734M 31.55B | EV / Sales 2026 * |
2.43x | EV / Sales 2027 * | 3.01x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
Tradegate
| PBDA | Real-time | |
Börse Stuttgart
| PBDA | Delayed | |
Deutsche Boerse AG
| PBDA | Delayed | |
Boerse Muenchen
| PBDA | Real-time |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | +2.02% | ||
| 1 week | -1.17% | ||
| Current month | -8.33% | ||
| 1 month | -6.99% | ||
| 3 months | +6.75% | ||
| 6 months | +16.06% | ||
| Current year | +40.56% |
| 1 week | 2.46 | 2.64 | |
| 1 month | 2.46 | 2.82 | |
| Current year | 1.72 | 3.19 | |
| 1 year | 1.65 | 3.19 | |
| 3 years | 0.82 | 3.19 | |
| 5 years | 0.7 | 3.55 | |
| 10 years | 0.7 | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 30/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 24/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 01/07/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 01/11/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 30/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Free | Director | 25,500 | 0.0316% | ||
| 03/09/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 03/09/26 | Free | Chief Executive Officer | 480,000 | 0.5957% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.02% | -1.17% | +7.20% | +69.80% | 200M | ||
| +0.22% | +3.35% | +55.30% | +125.65% | 1,140B | ||
| +0.91% | +5.89% | +41.14% | +80.36% | 641B | ||
| -0.12% | +1.31% | +25.62% | +97.24% | 507B | ||
| +0.63% | +4.97% | +47.12% | +68.18% | 383B | ||
| +0.86% | -1.26% | +62.10% | +34.36% | 347B | ||
| +1.02% | +3.69% | +23.73% | +51.35% | 293B | ||
| -0.25% | +3.40% | +2.31% | +23.38% | 266B | ||
| +0.75% | +5.41% | +53.53% | +66.09% | 240B | ||
| +0.25% | +3.93% | +31.54% | +102.65% | 197B | ||
| Average | +0.66% | +2.32% | +34.96% | +71.90% | 401.4B | |
| Weighted average by Cap. | +0.55% | +2.98% | +42.01% | +84.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 82.16M 73.74M 68.09M 61.74M 115M 7.8B 117M 816M 324M 4.09B 308M 302M 12.97B | 66.48M 59.67M 55.09M 49.96M 93.37M 6.31B 94.52M 661M 262M 3.31B 250M 244M 10.5B |
| Net income | 19.63M 17.62M 16.27M 14.75M 27.57M 1.86B 27.91M 195M 77.47M 977M 73.69M 72.12M 3.1B | 3.79M 3.41M 3.14M 2.85M 5.33M 360M 5.39M 37.7M 14.97M 189M 14.24M 13.94M 599M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | $2.530 | +2.02% | 448,302 |
| 26/10/26 | $2.480 | -2.75% | 416,271 |
| 23/10/26 | $2.550 | -0.78% | 383,908 |
| 22/10/26 | $2.570 | 0.00% | 457,114 |
| 21/10/26 | $2.570 | -2.65% | 561,517 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions

















